Overall market sentiment has been down on Enzo Biochem Inc (ENZ) stock lately. ENZ receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.
Enzo Biochem Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ENZ!
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With ENZ Stock Today?
Enzo Biochem Inc (ENZ) stock is down -10.99% while the S&P 500 is higher by 0.15% as of 10:23 AM on Tuesday, Jul 11. ENZ has fallen -$0.20 from the previous closing price of $1.82 on volume of 207,215 shares. Over the past year the S&P 500 has risen 14.58% while ENZ has fallen -26.36%. ENZ lost -$0.93 per share in the over the last 12 months.
More About Enzo Biochem Inc
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Click Here to get the full Stock Report for Enzo Biochem Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
